Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response.

Wang X, Takagawa J, Lam VC, Haddad DJ, Tobler DL, Mok PY, Zhang Y, Clifford BT, Pinnamaneni K, Saini SA, Su R, Bartel MJ, Sievers RE, Carbone L, Kogan S, Yeghiazarians Y, Hermiston M, Springer ML.

Sci Transl Med. 2011 Sep 14;3(100):100ra90. doi: 10.1126/scitranslmed.3002814.

2.

Age-dependent availability and functionality of bone marrow stem cells in an experimental model of acute and chronic myocardial infarction.

Ayala-Lugo A, Tavares AM, Paz AH, Alegretti A, Miquelito L, Bock H, Giugliani R, Clausell N, Cirne-Lima E, Rohde LE.

Cell Transplant. 2011;20(3):407-19. doi: 10.3727/096368909X519283.

PMID:
21535915
3.

Timing of bone marrow cell therapy is more important than repeated injections after myocardial infarction.

Zhang Y, Sievers RE, Prasad M, Mirsky R, Shih H, Wong ML, Angeli FS, Ye J, Takagawa J, Koskenvuo JW, Springer ML, Grossman W, Boyle AJ, Yeghiazarians Y.

Cardiovasc Pathol. 2011 Jul-Aug;20(4):204-12. doi: 10.1016/j.carpath.2010.06.007.

PMID:
20667749
4.

Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy.

Yeghiazarians Y, Zhang Y, Prasad M, Shih H, Saini SA, Takagawa J, Sievers RE, Wong ML, Kapasi NK, Mirsky R, Koskenvuo J, Minasi P, Ye J, Viswanathan MN, Angeli FS, Boyle AJ, Springer ML, Grossman W.

Mol Ther. 2009 Jul;17(7):1250-6. doi: 10.1038/mt.2009.85.

5.

How stem cells age and why this makes us grow old.

Sharpless NE, DePinho RA.

Nat Rev Mol Cell Biol. 2007 Sep;8(9):703-13. Review.

PMID:
17717515
6.

Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress.

Luptak I, Yan J, Cui L, Jain M, Liao R, Tian R.

Circulation. 2007 Aug 21;116(8):901-9.

7.

Cellular senescence in cancer and aging.

Collado M, Blasco MA, Serrano M.

Cell. 2007 Jul 27;130(2):223-33. Review.

8.

Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure.

Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, Fischer-Rasokat U, Heeschen C, Spyridopoulos I, Dimmeler S, Zeiher AM.

J Am Coll Cardiol. 2007 Jun 19;49(24):2341-9.

9.

Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age.

Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL.

Nature. 2007 Jun 7;447(7145):725-9.

PMID:
17554309
10.

Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches.

Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, Wang Y, Yeghiazarians Y, Lee RJ, Grossman W, Springer ML.

J Appl Physiol (1985). 2007 Jun;102(6):2104-11.

11.

Bone marrow Oct3/4+ cells differentiate into cardiac myocytes via age-dependent paracrine mechanisms.

Pallante BA, Duignan I, Okin D, Chin A, Bressan MC, Mikawa T, Edelberg JM.

Circ Res. 2007 Jan 5;100(1):e1-11.

12.

Cardiac cell therapy--mixed results from mixed cells.

Rosenzweig A.

N Engl J Med. 2006 Sep 21;355(12):1274-7. No abstract available.

13.

Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI Investigators..

N Engl J Med. 2006 Sep 21;355(12):1210-21.

14.

Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling.

Lehrke S, Mazhari R, Durand DJ, Zheng M, Bedja D, Zimmet JM, Schuleri KH, Chi AS, Gabrielson KL, Hare JM.

Circ Res. 2006 Sep 1;99(5):553-60.

15.

Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy.

Zhang H, Fazel S, Tian H, Mickle DA, Weisel RD, Fujii T, Li RK.

Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H2089-96.

16.

Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography.

Springer ML, Sievers RE, Viswanathan MN, Yee MS, Foster E, Grossman W, Yeghiazarians Y.

Am J Physiol Heart Circ Physiol. 2005 Sep;289(3):H1307-14.

17.

Impaired progenitor cell activity in age-related endothelial dysfunction.

Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C.

J Am Coll Cardiol. 2005 May 3;45(9):1441-8.

18.

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ.

Nat Med. 2005 Apr;11(4):367-8. No abstract available.

PMID:
15812508
19.

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H.

Lancet. 2004 Jul 10-16;364(9429):141-8.

PMID:
15246726
20.

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.

Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S.

Circulation. 2004 Apr 6;109(13):1615-22.

Supplemental Content

Support Center